Northland Capmk Predicts Astera Labs FY2026 Earnings

Astera Labs, Inc. (NASDAQ:ALAB) – Equities researchers at Northland Capmk issued their FY2026 earnings per share (EPS) estimates for shares of Astera Labs in a research note issued on Thursday, January 2nd. Northland Capmk analyst G. Richard forecasts that the company will post earnings per share of $0.71 for the year. Northland Capmk has a “Hold” rating on the stock. The consensus estimate for Astera Labs’ current full-year earnings is ($0.45) per share.

Astera Labs (NASDAQ:ALAB) last released its earnings results on Monday, November 4th. The company reported $0.23 EPS for the quarter, topping the consensus estimate of $0.17 by $0.06. The firm had revenue of $113.10 million for the quarter, compared to the consensus estimate of $97.50 million. Astera Labs had a negative net margin of 30.69% and a negative return on equity of 15.57%. The company’s revenue for the quarter was up 47.1% compared to the same quarter last year.

ALAB has been the topic of a number of other reports. Roth Mkm boosted their target price on Astera Labs from $80.00 to $105.00 and gave the stock a “buy” rating in a research report on Tuesday, November 5th. Needham & Company LLC reiterated a “buy” rating and set a $65.00 target price on shares of Astera Labs in a research report on Wednesday, October 9th. Barclays boosted their price target on shares of Astera Labs from $70.00 to $87.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 5th. Craig Hallum increased their price objective on shares of Astera Labs from $75.00 to $105.00 and gave the company a “buy” rating in a research report on Tuesday, November 5th. Finally, Morgan Stanley boosted their target price on shares of Astera Labs from $94.00 to $142.00 and gave the stock an “overweight” rating in a report on Friday, December 20th. Two investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. According to data from MarketBeat, Astera Labs has a consensus rating of “Moderate Buy” and a consensus target price of $105.75.

Astera Labs Trading Up 1.9 %

Shares of ALAB stock opened at $143.64 on Monday. The company’s fifty day simple moving average is $111.04 and its two-hundred day simple moving average is $72.22. Astera Labs has a 52 week low of $36.22 and a 52 week high of $147.39.

Institutional Trading of Astera Labs

A number of large investors have recently modified their holdings of ALAB. Hollencrest Capital Management purchased a new position in Astera Labs during the 3rd quarter worth $26,000. GAMMA Investing LLC increased its stake in shares of Astera Labs by 78.3% during the fourth quarter. GAMMA Investing LLC now owns 510 shares of the company’s stock valued at $68,000 after buying an additional 224 shares during the period. US Bancorp DE bought a new stake in shares of Astera Labs in the third quarter valued at about $46,000. First Horizon Advisors Inc. bought a new stake in shares of Astera Labs in the 3rd quarter valued at about $49,000. Finally, Allworth Financial LP lifted its position in shares of Astera Labs by 445.5% in the 3rd quarter. Allworth Financial LP now owns 1,091 shares of the company’s stock worth $57,000 after purchasing an additional 891 shares during the period. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Insider Buying and Selling at Astera Labs

In related news, Director Jack R. Lazar sold 3,000 shares of Astera Labs stock in a transaction dated Wednesday, October 9th. The shares were sold at an average price of $61.69, for a total transaction of $185,070.00. Following the completion of the sale, the director now owns 137,000 shares in the company, valued at $8,451,530. This trade represents a 2.14 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, General Counsel Philip Mazzara sold 25,000 shares of the company’s stock in a transaction dated Wednesday, October 9th. The stock was sold at an average price of $60.74, for a total transaction of $1,518,500.00. Following the completion of the transaction, the general counsel now owns 300,564 shares in the company, valued at $18,256,257.36. This represents a 7.68 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 1,978,119 shares of company stock worth $186,618,509 over the last 90 days.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.